Alan Brochstein, CFA
Contrarian, growth at reasonable price, management change, cannabis stocks

Plandaí­ Biotechnology: Avoid This Green Tea Fantasy

Plandaí­ Biotechnology (OTCPK:PLPL), "headquartered" in Seattle, is seeking to "transform the world of nutraceuticals" by growing green tea in South Africa and employing specialized extraction technologies in order to produce a highly bioavailable green tea gallate catechin. The company believes that it can potentially cure malaria, and it also suggests that its "Phytofare Catechin Complex" may lead to weight loss among many other possible positive health indications, like curing cancer or HIV. While these are significant opportunities to address large problems that have led investors to drive PLPL up over 1000% in 2013, a careful review of the company's background and financials reveals many red flags that suggest investors are at risk of losing their entire investment. With...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details